肌肌酸激酶(CKM)單克隆抗體
Monoclonal Antibody to Creatine Kinase, Muscle (CKM)
CK-MM; CKMM; CK3; CK-M; MM-CK; M-CK; Creatine kinase M-type, N-terminally processed
- 編號UMAA109Hu23
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源單抗制備
- 宿主小鼠
- 效價(克隆號)H34
- Ig亞型 IgG2b Kappa
- 純化方式蛋白A + 蛋白G親和純化
- 標記物無標記物
- 免疫原 RPA109Hu01-肌肌酸激酶(CKM)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度1mg/ml
- 且適物種Mus musculus (Mouse，小鼠), Rattus norvegicus (Rat，大鼠)
- 應用WB; IHC
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 307 ¥ 716 ¥ 1023 ¥ 2558 ¥ 10230
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
DAB staining on IHC-P; Sample: Rat Skeletal muscle Tissue; Primary Ab: 20μg/ml Mouse Anti-Human CKM Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
-
DAB staining on IHC-P;
Sample: Rat Cardiac Muscle Tissue;
Primary Ab: 20μg/ml Mouse Anti-Human CKM Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19) -
DAB staining on IHC-P;
Sample: Rat Cardiac Muscle Tissue
Primary Ab: 20μg/ml Mouse Anti-Human CKM Antibody
Control: Used PBS instead of primary antibody
Second Ab: 2μg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19) -
DAB staining on IHC-P;
Sample: Rat Skeletal muscle Tissue
Primary Ab: 20μg/ml Mouse Anti-Human CKM Antibody
Control: Used PBS instead of primary antibody
Second Ab: 2μg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
-
Western Blot; Sample: Lane1: Rat Heart lysate; Lane2: Rat Skeletal muscle lysate Primary Ab: 0.1μg/ml Mouse Anti-Human CKM Antibody Second Ab: 0.2μg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
-
Western Blot; Sample: Lane1: Mouse Heart lysate; Lane2: Mouse Skeletal muscle lysate
Primary Ab: 0.3μg/ml Mouse Anti-Human CKM Antibody
Second Ab: 0.2μg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
-
通過ISO 9001、ISO 13485質(zhì)量體系認證
特異性
該抗體是針對CKM的小鼠單克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別CKM。
用法
Western blotting: 0.5-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務
相關產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| URPA109Hu01 | 肌肌酸激酶(CKM)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAA109Hu01 | 肌肌酸激酶(CKM)多克隆抗體 | WB; IHC |
| ULAA109Hu71 | 肌肌酸激酶(CKM)多克隆抗體(生物素標記) | WB |
| UMAA109Hu27 | 肌肌酸激酶(CKM)單克隆抗體 | WB |
| UMAA109Hu29 | 肌肌酸激酶(CKM)單克隆抗體 | WB |
| UMAA109Hu26 | 肌肌酸激酶(CKM)單克隆抗體 | ICC/IF |
| UMAA109Hu23 | 肌肌酸激酶(CKM)單克隆抗體 | WB; IHC |
| UMAA109Hu24 | 肌肌酸激酶(CKM)單克隆抗體 | WB; IHC |
| UMAA109Hu25 | 肌肌酸激酶(CKM)單克隆抗體 | WB; IHC |
| UMAA109Hu22 | 肌肌酸激酶(CKM)單克隆抗體 | WB; IHC |
| UMAA109Hu28 | 肌肌酸激酶(CKM)單克隆抗體 | WB; ICC/IF; FCM |
| UMAA109Hu21 | 肌肌酸激酶(CKM)單克隆抗體 | WB; IHC |
| UFAA109Hu08 | 抗肌肌酸激酶(CKM)單克隆抗體 | FCM |
| UFAA109Hu06 | 抗肌肌酸激酶(CKM)單克隆抗體 | FCM |
| UFAA109Hu04 | 抗肌肌酸激酶(CKM)單克隆抗體 | FCM |
| UFAA109Hu02 | 抗肌肌酸激酶(CKM)單克隆抗體 | FCM |
| USEA109Hu | 肌肌酸激酶(CKM)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| ULMA109Hu | 肌肌酸激酶(CKM)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| UKSA109Hu01 | 肌肌酸激酶(CKM)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
| 雜志 | 參考文獻 |
| Journal of Inflammation | Assessment of endothelium and inflammatory response at the onset of reperfusion injury in hand surgery [PubMed: 22583529] |
| PLoS One | Extraocular Muscle Characteristics Related to Myasthenia Gravis Susceptibility [PubMed: PMC3568149] |
| Kidney Int. | Fructokinase activity mediates dehydration-induced renal injury [Pubmed: 24336030] |
| Methylxanthines and cardiotoxicity | Methylxanthine induced cardiotoxicity and its mechanisms: An experimental study [230b:34bf146150b42971d76dda5e8329bc5f2f0b.pdf] |
| Molecular Medicine Reports | Protective effects of N (2)?L?alanyl?L?glutamine mediated by the JAK2/STAT3 signaling pathway on myocardial ischemia reperfusion [Pubmed:29393473] |
| Toxicological?Sciences | Proteomic and Metabolomic Profiling Identify Plasma Biomarkers for Exposure to Ultra-low Levels of Carfentanil [Pubmed: 30321427] |
| Clinical & Translational Oncology | The effects of human sera conditioned by high-intensity exercise sessions and training on the tumorigenic potential of cancer cells [Pubmed: 32447643] |
留言咨詢
